Does the media favor GH or CELC?

In the previous week, Guardant Health had 9 more articles in the media than Celcuity. MarketBeat recorded 12 mentions for Guardant Health and 3 mentions for Celcuity. Celcuity's average media sentiment score of 0.62 beat Guardant Health's score of 0.52 indicating that Celcuity is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 1 Very Positive mention(s) 5 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Celcuity 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to CELC or BTSG?

In the previous week, Celcuity had 1 more articles in the media than BrightSpring Health Services. MarketBeat recorded 3 mentions for Celcuity and 2 mentions for BrightSpring Health Services. Celcuity's average media sentiment score of 0.62 beat BrightSpring Health Services' score of 0.43 indicating that Celcuity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Celcuity 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BrightSpring Health Services 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor CELC or FMS?

In the previous week, Celcuity had 1 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 3 mentions for Celcuity and 2 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.07 beat Celcuity's score of 0.62 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Celcuity 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Fresenius Medical Care AG & Co. KGaA 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor CELC or HIMS?

In the previous week, Hims & Hers Health had 13 more articles in the media than Celcuity. MarketBeat recorded 16 mentions for Hims & Hers Health and 3 mentions for Celcuity. Hims & Hers Health's average media sentiment score of 0.64 beat Celcuity's score of 0.62 indicating that Hims & Hers Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Celcuity 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 6 Very Positive mention(s) 7 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings and valuation, CELC or PACS?

PACS Group has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Celcuity N/A N/A -$177.04M -$3.90 N/A PACS Group $5.29B 1.20 $191.54M $1.56 25.60

Is CELC or PACS more profitable?

PACS Group has a net margin of 4.49% compared to Celcuity's net margin of 0.00%. PACS Group's return on equity of 26.47% beat Celcuity's return on equity. Company Net Margins Return on Equity Return on Assets Celcuity N/A -244.61% -50.22% PACS Group 4.49% 26.47% 4.36%

Does the media prefer CELC or PACS?

In the previous week, PACS Group had 15 more articles in the media than Celcuity. MarketBeat recorded 18 mentions for PACS Group and 3 mentions for Celcuity. Celcuity's average media sentiment score of 0.62 beat PACS Group's score of 0.08 indicating that Celcuity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Celcuity 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PACS Group 4 Very Positive mention(s) 3 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Celcuity (CELC) Competitors

$102.52 +2.57 (+2.57%)

Closing price 04:00 PM Eastern

Extended Trading

$102.90 +0.38 (+0.37%)

As of 07:58 PM Eastern

Compare

CELC vs. GH, BTSG, FMS, HIMS, and PACS

Should you buy Celcuity stock or one of its competitors? MarketBeat compares Celcuity with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Celcuity include Guardant Health (GH), BrightSpring Health Services (BTSG), Fresenius Medical Care AG & Co. KGaA (FMS), Hims & Hers Health (HIMS), and PACS Group (PACS). These companies are all part of the "healthcare" industry.

How does Celcuity compare to Guardant Health?

Guardant Health (NASDAQ:GH) and Celcuity (NASDAQ:CELC) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, earnings, risk, media sentiment, valuation, analyst recommendations and institutional ownership.

92.6% of Guardant Health shares are held by institutional investors. Comparatively, 63.3% of Celcuity shares are held by institutional investors. 5.6% of Guardant Health shares are held by insiders. Comparatively, 13.3% of Celcuity shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Guardant Health has a beta of 1.61, meaning that its stock price is 61% more volatile than the broader market. Comparatively, Celcuity has a beta of 0.1, meaning that its stock price is 90% less volatile than the broader market.

Guardant Health currently has a consensus price target of $144.82, indicating a potential downside of 5.80%. Celcuity has a consensus price target of $152.09, indicating a potential upside of 48.35%. Given Celcuity's higher possible upside, analysts plainly believe Celcuity is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	21 Buy rating(s)	2 Strong Buy rating(s)	3.00
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83

Celcuity has a net margin of 0.00% compared to Guardant Health's net margin of -40.10%. Guardant Health's return on equity of 0.00% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-40.10%	N/A	-26.42%
Celcuity	N/A	-244.61%	-50.22%

In the previous week, Guardant Health had 9 more articles in the media than Celcuity. MarketBeat recorded 12 mentions for Guardant Health and 3 mentions for Celcuity. Celcuity's average media sentiment score of 0.62 beat Guardant Health's score of 0.52 indicating that Celcuity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	1 Very Positive mention(s)	5 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Celcuity	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Celcuity has lower revenue, but higher earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Celcuity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$982.02M	20.76	-$416.28M	-$3.39	N/A
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A

Summary

Guardant Health beats Celcuity on 10 of the 16 factors compared between the two stocks.

How does Celcuity compare to BrightSpring Health Services?

Celcuity (NASDAQ:CELC) and BrightSpring Health Services (NASDAQ:BTSG) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, media sentiment, earnings, dividends and analyst recommendations.

Celcuity presently has a consensus price target of $152.09, indicating a potential upside of 48.35%. BrightSpring Health Services has a consensus price target of $61.27, indicating a potential downside of 11.18%. Given Celcuity's higher probable upside, equities analysts clearly believe Celcuity is more favorable than BrightSpring Health Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	16 Buy rating(s)	2 Strong Buy rating(s)	3.11

In the previous week, Celcuity had 1 more articles in the media than BrightSpring Health Services. MarketBeat recorded 3 mentions for Celcuity and 2 mentions for BrightSpring Health Services. Celcuity's average media sentiment score of 0.62 beat BrightSpring Health Services' score of 0.43 indicating that Celcuity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Celcuity	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
BrightSpring Health Services	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

BrightSpring Health Services has a net margin of 2.27% compared to Celcuity's net margin of 0.00%. BrightSpring Health Services' return on equity of 14.63% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Celcuity	N/A	-244.61%	-50.22%
BrightSpring Health Services	2.27%	14.63%	4.41%

63.3% of Celcuity shares are owned by institutional investors. 13.3% of Celcuity shares are owned by company insiders. Comparatively, 2.8% of BrightSpring Health Services shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Celcuity has a beta of 0.1, suggesting that its stock price is 90% less volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.87, suggesting that its stock price is 87% more volatile than the broader market.

BrightSpring Health Services has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A
BrightSpring Health Services	$12.91B	1.05	$190.67M	$1.41	48.92

Summary

BrightSpring Health Services beats Celcuity on 11 of the 16 factors compared between the two stocks.

How does Celcuity compare to Fresenius Medical Care AG & Co. KGaA?

Celcuity (NASDAQ:CELC) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability, media sentiment and risk.

63.3% of Celcuity shares are held by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. 13.3% of Celcuity shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.55	$1.11B	$1.90	11.97

Celcuity presently has a consensus target price of $152.09, indicating a potential upside of 48.35%. Fresenius Medical Care AG & Co. KGaA has a consensus target price of $28.00, indicating a potential upside of 23.09%. Given Celcuity's stronger consensus rating and higher probable upside, equities analysts clearly believe Celcuity is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.44

In the previous week, Celcuity had 1 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 3 mentions for Celcuity and 2 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.07 beat Celcuity's score of 0.62 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Celcuity	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Fresenius Medical Care AG & Co. KGaA	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to Celcuity's net margin of 0.00%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Celcuity	N/A	-244.61%	-50.22%
Fresenius Medical Care AG & Co. KGaA	4.88%	8.90%	4.05%

Celcuity has a beta of 0.1, meaning that its share price is 90% less volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.8, meaning that its share price is 20% less volatile than the broader market.

Summary

Fresenius Medical Care AG & Co. KGaA beats Celcuity on 9 of the 15 factors compared between the two stocks.

How does Celcuity compare to Hims & Hers Health?

Celcuity (NASDAQ:CELC) and Hims & Hers Health (NYSE:HIMS) are both mid-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, profitability, risk, analyst recommendations, valuation, earnings and institutional ownership.

63.3% of Celcuity shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 13.3% of Celcuity shares are held by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Celcuity has a beta of 0.1, suggesting that its share price is 90% less volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.37, suggesting that its share price is 137% more volatile than the broader market.

In the previous week, Hims & Hers Health had 13 more articles in the media than Celcuity. MarketBeat recorded 16 mentions for Hims & Hers Health and 3 mentions for Celcuity. Hims & Hers Health's average media sentiment score of 0.64 beat Celcuity's score of 0.62 indicating that Hims & Hers Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Celcuity	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hims & Hers Health	6 Very Positive mention(s)	7 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Celcuity has a net margin of 0.00% compared to Hims & Hers Health's net margin of -0.56%. Hims & Hers Health's return on equity of 6.10% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Celcuity	N/A	-244.61%	-50.22%
Hims & Hers Health	-0.56%	6.10%	1.52%

Celcuity currently has a consensus target price of $152.09, suggesting a potential upside of 48.35%. Hims & Hers Health has a consensus target price of $29.37, suggesting a potential downside of 11.96%. Given Celcuity's stronger consensus rating and higher probable upside, equities research analysts plainly believe Celcuity is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83
Hims & Hers Health	2 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.13

Hims & Hers Health has higher revenue and earnings than Celcuity. Hims & Hers Health is trading at a lower price-to-earnings ratio than Celcuity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A
Hims & Hers Health	$2.35B	3.29	$128.37M	-$0.09	N/A

Summary

Hims & Hers Health beats Celcuity on 9 of the 15 factors compared between the two stocks.

How does Celcuity compare to PACS Group?

Celcuity (NASDAQ:CELC) and PACS Group (NYSE:PACS) are both mid-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, media sentiment, institutional ownership, dividends, profitability and earnings.

PACS Group has a net margin of 4.49% compared to Celcuity's net margin of 0.00%. PACS Group's return on equity of 26.47% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Celcuity	N/A	-244.61%	-50.22%
PACS Group	4.49%	26.47%	4.36%

Celcuity presently has a consensus price target of $152.09, suggesting a potential upside of 48.35%. PACS Group has a consensus price target of $48.00, suggesting a potential upside of 20.19%. Given Celcuity's stronger consensus rating and higher probable upside, research analysts clearly believe Celcuity is more favorable than PACS Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71

PACS Group has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A
PACS Group	$5.29B	1.20	$191.54M	$1.56	25.60

63.3% of Celcuity shares are owned by institutional investors. 13.3% of Celcuity shares are owned by company insiders. Comparatively, 70.1% of PACS Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, PACS Group had 15 more articles in the media than Celcuity. MarketBeat recorded 18 mentions for PACS Group and 3 mentions for Celcuity. Celcuity's average media sentiment score of 0.62 beat PACS Group's score of 0.08 indicating that Celcuity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Celcuity	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
PACS Group	4 Very Positive mention(s)	3 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

PACS Group beats Celcuity on 9 of the 14 factors compared between the two stocks.

Get Celcuity News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CELC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CELC vs. The Competition

Export

Metric	Celcuity	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$4.87B	$3.62B	$6.85B	$12.20B
Dividend Yield	N/A	2.21%	2.66%	6.22%
P/E Ratio	-26.29	20.93	26.04	24.36
Price / Sales	N/A	342.90	550.17	103.06
Price / Cash	N/A	62.10	29.09	36.93
Price / Book	47.24	8.71	10.98	6.49
Net Income	-$177.04M	$23.87M	$3.57B	$336.61M
7 Day Performance	14.00%	4.23%	3.06%	0.90%
1 Month Performance	-22.85%	1.71%	0.72%	-0.36%
1 Year Performance	717.54%	69.92%	36.82%	31.26%

Celcuity Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CELC Celcuity	3.4921 of 5 stars	$102.52 +2.6%	$152.09 +48.4%	+697.0%	$4.87B	N/A	N/A	40
GH Guardant Health	1.902 of 5 stars	$130.87 +1.6%	$141.95 +8.5%	+193.4%	$17.35B	$982.02M	N/A	2,506	Analyst Forecast
BTSG BrightSpring Health Services	3.3454 of 5 stars	$67.60 +0.6%	$61.27 -9.4%	+193.0%	$13.32B	$12.91B	47.87	23,500
FMS Fresenius Medical Care AG & Co. KGaA	4.65 of 5 stars	$23.80 +1.7%	$28.00 +17.7%	-17.7%	$12.86B	$19.36B	12.53	1,488	Positive News
HIMS Hims & Hers Health	2.504 of 5 stars	$33.94 +1.2%	$29.37 -13.5%	-31.5%	$7.83B	$2.35B	N/A	2,442

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CELC) was last updated on 6/29/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Celcuity (CELC) Competitors

CELC vs. GH, BTSG, FMS, HIMS, and PACS

How does Celcuity compare to Guardant Health?

Summary

How does Celcuity compare to BrightSpring Health Services?

Summary

How does Celcuity compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does Celcuity compare to Hims & Hers Health?

Summary

How does Celcuity compare to PACS Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CELC vs. The Competition

Celcuity Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Celcuity (CELC) Competitors

CELC vs. GH, BTSG, FMS, HIMS, and PACS

How does Celcuity compare to Guardant Health?

Do insiders and institutionals hold more shares of GH or CELC?

Which has more volatility & risk, GH or CELC?

Do analysts prefer GH or CELC?

Is GH or CELC more profitable?

Does the media favor GH or CELC?

Which has preferable valuation & earnings, GH or CELC?

Summary

How does Celcuity compare to BrightSpring Health Services?

Do analysts recommend CELC or BTSG?

Does the media refer more to CELC or BTSG?

Is CELC or BTSG more profitable?

Do institutionals and insiders believe in CELC or BTSG?

Which has more volatility & risk, CELC or BTSG?

Which has higher earnings and valuation, CELC or BTSG?

Summary

How does Celcuity compare to Fresenius Medical Care AG & Co. KGaA?

Do institutionals & insiders hold more shares of CELC or FMS?

Which has preferable valuation & earnings, CELC or FMS?

Do analysts rate CELC or FMS?

Does the media favor CELC or FMS?

Is CELC or FMS more profitable?

Which has more volatility & risk, CELC or FMS?

Summary

How does Celcuity compare to Hims & Hers Health?

Do insiders & institutionals hold more shares of CELC or HIMS?

Which has more volatility and risk, CELC or HIMS?

Does the media favor CELC or HIMS?

Is CELC or HIMS more profitable?

Do analysts prefer CELC or HIMS?

Which has better earnings and valuation, CELC or HIMS?

Summary

How does Celcuity compare to PACS Group?

Is CELC or PACS more profitable?

Do analysts prefer CELC or PACS?

Which has preferable earnings and valuation, CELC or PACS?

Do insiders and institutionals have more ownership in CELC or PACS?

Does the media prefer CELC or PACS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CELC vs. The Competition

Celcuity Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools